Myeloma Patients Crave Breaks From Treatment but Keep Their Check-Ups
A survey of 100 multiple myeloma patients in Germany finds that nearly half highly value treatment-free intervals for recovery, yet ...
A survey of 100 multiple myeloma patients in Germany finds that nearly half highly value treatment-free intervals for recovery, yet ...
An international adaptive platform trial called Glo-BNHL will simultaneously test bispecific antibodies, antibody-drug conjugates and CAR T-cells in children and ...
A new first-person perspective in Advances in Therapy follows a music professor through repeated myeloma relapses to talquetamab therapy, revealing ...
A comprehensive review details how antibody–drug conjugates targeting TROP2, HER2, c-MET, and other antigens are transforming non-small cell lung cancer ...
Researchers at University Hospital Tübingen have engineered NG2-targeting bispecific antibodies that redirect T cells to kill melanoma cells, with a ...
Updated 2026 expert recommendations provide a comprehensive, evidence-graded framework for preventing, diagnosing and treating the rare but often fatal myocarditis ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine